Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 26:10:1157651.
doi: 10.3389/fmolb.2023.1157651. eCollection 2023.

Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets

Affiliations
Review

Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets

Grace Kenny et al. Front Mol Biosci. .

Abstract

The emergence of persistent ill-health in the aftermath of SARS-CoV-2 infection has presented significant challenges to patients, healthcare workers and researchers. Termed long COVID, or post-acute sequelae of COVID-19 (PASC), the symptoms of this condition are highly variable and span multiple body systems. The underlying pathophysiology remains poorly understood, with no therapeutic agents proven to be effective. This narrative review describes predominant clinical features and phenotypes of long COVID alongside the data supporting potential pathogenesis of these phenotypes including ongoing immune dysregulation, viral persistence, endotheliopathy, gastrointestinal microbiome disturbance, autoimmunity, and dysautonomia. Finally, we describe current potential therapies under investigation, as well as future potential therapeutic options based on the proposed pathogenesis research.

Keywords: PASC; SARS-CoV-2; long COVID; post COVID condition; post-acute sequelae of SARS-CoV-2 infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Multisystem symptoms associated with long COVID. Legend: Selection of symptoms reported by patients suffering with long COVID, demonstrating the multi-system nature of the disease. Created with BioRender.com.
FIGURE 2
FIGURE 2
Hypothesised sequelae of SARS-CoV-2 that lead to long COVID. Legend: A selection of the possible sequelae of SARS-CoV-2 that may lead to the various post-acute pathologies that occur in a subset of individuals.
FIGURE 3
FIGURE 3
Proposed mechanisms of long COVID. Legend: Multiple possible precipitants, including persistent virus, reactivation of latent viruses, altered microbiome, endothelial dysfunction, and autoimmunity, may lead to ongoing immune activation and subsequent systemic symptoms. Created with BioRender.com.

References

    1. Al-Aly Z., Bowe B., Xie Y. (2022). Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 28 (7), 1461–1467. 10.1038/s41591-022-01840-0 - DOI - PMC - PubMed
    1. Al-Aly Z., Xie Y., Bowe B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature 594 (7862), 259–264. 10.1038/s41586-021-03553-9 - DOI - PubMed
    1. Alam S., Willows S., Kulka M., Sandhu J. K. (2020). Severe acute respiratory syndrome coronavirus 2 may be an underappreciated pathogen of the central nervous system. Eur. J. neurology 27 (11), 2348–2360. 10.1111/ene.14442 - DOI - PMC - PubMed
    1. Alba G. A., Ziehr D. R., Rouvina J. N., Hariri L. P., Knipe R. S., Medoff B. D., et al. (2021). Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea. EClinicalMedicine 39, 101066. 10.1016/j.eclinm.2021.101066 - DOI - PMC - PubMed
    1. Antonelli M., Penfold R. S., Merino J., Sudre C. H., Molteni E., Berry S., et al. (2022). Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: A prospective, community-based, nested, case-control study. Lancet Infect. Dis. 22 (1), 43–55. 10.1016/S1473-3099(21)00460-6 - DOI - PMC - PubMed